Impax Asset Management Group plc Has $95.77 Million Holdings in Waters Corporation $WAT

Impax Asset Management Group plc lessened its position in shares of Waters Corporation (NYSE:WAT) by 35.4% in the second quarter, Holdings Channel.com reports. The firm owned 274,368 shares of the medical instruments supplier’s stock after selling 150,385 shares during the period. Impax Asset Management Group plc’s holdings in Waters were worth $95,765,000 as of its most recent SEC filing.

A number of other hedge funds have also modified their holdings of the company. UMB Bank n.a. boosted its position in Waters by 2.8% during the 2nd quarter. UMB Bank n.a. now owns 1,055 shares of the medical instruments supplier’s stock worth $368,000 after acquiring an additional 29 shares during the last quarter. Integrated Wealth Concepts LLC boosted its holdings in Waters by 2.9% during the first quarter. Integrated Wealth Concepts LLC now owns 1,048 shares of the medical instruments supplier’s stock worth $386,000 after purchasing an additional 30 shares during the last quarter. FourThought Financial Partners LLC grew its position in Waters by 5.1% in the first quarter. FourThought Financial Partners LLC now owns 658 shares of the medical instruments supplier’s stock valued at $243,000 after purchasing an additional 32 shares in the last quarter. Penserra Capital Management LLC grew its position in Waters by 13.1% in the second quarter. Penserra Capital Management LLC now owns 327 shares of the medical instruments supplier’s stock valued at $114,000 after purchasing an additional 38 shares in the last quarter. Finally, Horizon Investments LLC increased its stake in Waters by 5.2% in the 1st quarter. Horizon Investments LLC now owns 852 shares of the medical instruments supplier’s stock valued at $314,000 after buying an additional 42 shares during the last quarter. 94.01% of the stock is currently owned by institutional investors.

Wall Street Analysts Forecast Growth

A number of equities analysts have recently commented on WAT shares. Wall Street Zen downgraded shares of Waters from a “buy” rating to a “hold” rating in a research note on Saturday, July 26th. TD Cowen raised their price target on Waters from $345.00 to $390.00 and gave the company a “hold” rating in a research note on Wednesday, November 5th. Redburn Partners set a $390.00 price objective on Waters in a research note on Wednesday, October 8th. Jefferies Financial Group set a $385.00 price objective on Waters and gave the company a “buy” rating in a report on Monday, August 4th. Finally, Robert W. Baird lowered their target price on shares of Waters from $374.00 to $352.00 and set an “outperform” rating on the stock in a report on Wednesday, July 16th. Two investment analysts have rated the stock with a Strong Buy rating, six have assigned a Buy rating and nine have given a Hold rating to the stock. According to MarketBeat.com, Waters currently has a consensus rating of “Moderate Buy” and an average price target of $381.57.

Waters Stock Performance

NYSE WAT opened at $387.26 on Thursday. The stock has a market cap of $23.06 billion, a PE ratio of 34.92, a P/E/G ratio of 3.19 and a beta of 1.11. The company has a debt-to-equity ratio of 0.55, a quick ratio of 1.22 and a current ratio of 1.75. The firm has a 50-day moving average of $328.80 and a 200-day moving average of $327.04. Waters Corporation has a 52-week low of $275.05 and a 52-week high of $423.56.

Waters (NYSE:WAT) last announced its quarterly earnings results on Thursday, May 19th. The medical instruments supplier reported $2.29 EPS for the quarter. The business had revenue of $608.55 million for the quarter. Waters had a net margin of 21.71% and a return on equity of 38.60%. On average, sell-side analysts anticipate that Waters Corporation will post 12.86 EPS for the current year.

Waters Company Profile

Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments: Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans.